Breaking News

Solazyme COO Resigns

By Christine Esposito, Associate Editor | January 10, 2014

No plans to replace departing Jean-Marc Rotsaert.

Jean-Marc Rotsaert has resigned as chief operating officer at Solazyme, Inc, the renewable oil and bioproducts firm behind the Algenist skin care line.

With David Cole appointed as president in December 2013, Solazyme does not have plans to fill the COO position, according to CEO Jonathan Wolfson.

In addition, the company has appointed Robert Webber to the new position of SVP, strategic and operational planning, reporting to Cole. He will assume cross-functional responsibility for operating plans across the company.

Related End-User Markets:

blog comments powered by Disqus
  • Why Look Good, When You Can Look Perfect?

    Why Look Good, When You Can Look Perfect?

    Tom Branna, Editorial Director||April 4, 2016
    A new way to try-before-you buy is capturing the attention of consumers and the beauty industry.

  • NYSCC Explores Product Innovation

    NYSCC Explores Product Innovation

    Christine Esposito, Associate Editor||March 14, 2016
    New product development, formulation expertise and proper preservation are topics of discussion at February monthly meeting.

  • Battling Pollution via Skin Care

    Battling Pollution via Skin Care

    Christine Esposito, Associate Editor||March 7, 2016
    Canadian start-up turns to crowdfunding to help launch a new anti-pollution moisturizer.

  • Who Makes That?

    Who Makes That?

    Tom Branna, Editorial Director||April 1, 2016
    From concept and formulation to testing and filling, today’s contract manufacturers perform a range of services for marketers

  • Multi-Cultural Beauty Update

    Multi-Cultural Beauty Update

    Christine Esposito, Associate Editor||April 1, 2016
    Established brands and start-ups address the needs of multi-cultural beauty consumers.

  • The Scalp Microbiome

    The Scalp Microbiome

    Nava Dayan PhD, Dr. Nava Dayan LLC||April 1, 2016
    A review of recent findings and innovative approaches for treating scalp disorders.